Nogueira Almeida Larissa, Clauder Ann-Katrin, Meng Lingzhang, Ehlers Marc, Arce Sergio, Manz Rudolf Armin
Institute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Center for Systemic Inflammation Research (CSIR), School of Preclinical Medicine, Youjiang Medical University for Nationalities, Baise City (Bose), Guangxi Zhuang, Autonomous Region, China.
Eur J Immunol. 2022 Feb;52(2):197-203. doi: 10.1002/eji.202149279. Epub 2021 Oct 22.
Genome-wide association studies (GWAS) have identified many genes that are associated with the development of certain autoimmune disorders, but the MHC haplotypes still represent the most prevalent genetic risk factor for many autoimmune diseases. The mechanisms by which MHC-associated genetic susceptibility translates into B cell autoimmunity and the development of autoimmune diseases are complex. There is increasing evidence that the MHC haplotype modulates autoreactive B cell responses in multiple ways. Instead of merely inhibiting the production of IgG autoantibodies and mediating complete immunological tolerance, the non-permitting MHC haplotypes seem to facilitate the production of IgG autoantibodies exhibiting Fc glycosylation patterns that are associated with reduced pathogenicity and a protective cytokine profile of T follicular helper (Tfh) cells. Here, we discuss mechanisms linking MHC haplotypes to the production of pathogenic IgG autoantibodies, which could be relevant for the development of improved diagnosis, particularly in the context of individual medicine.
全基因组关联研究(GWAS)已鉴定出许多与某些自身免疫性疾病发生相关的基因,但MHC单倍型仍是许多自身免疫性疾病最常见的遗传风险因素。MHC相关的遗传易感性转化为B细胞自身免疫和自身免疫性疾病发生的机制很复杂。越来越多的证据表明,MHC单倍型以多种方式调节自身反应性B细胞反应。非允许性MHC单倍型似乎并非仅仅抑制IgG自身抗体的产生并介导完全的免疫耐受,而是促进产生具有Fc糖基化模式的IgG自身抗体,这些模式与致病性降低和滤泡辅助性T(Tfh)细胞的保护性细胞因子谱相关。在此,我们讨论将MHC单倍型与致病性IgG自身抗体产生联系起来的机制,这可能与改进诊断的发展相关,特别是在个体化医学背景下。